A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against the whole virus covering important antigens such as S-protein, RBD, and N-protein whereas currently approved vaccines in the US target only S-protein antigen"
The reports claimed that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine - Covaxin, "had to skip certain processes" and "speed" up clinical trials due to political pressure. The reports further claimed that there were several irregularities in the three phases of the clinical
Islamabad [Pakistan], August 27 (ANI): The United States on Friday donated nine million pediatric and adult doses of Covid-19 vaccines to Pakistan. "As part of the U.S. commitment to provide 77 million doses of US COVID-19 vaccines to Pakistan, an additional nine million pediatric and adult
New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has approved Biological E's Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.
Hyderabad [Telangana], August 5 (ANI): Hyderabad-based Bharat Biotech on Friday announced that Japan has approved the COVAXIN booster dose for travellers.
Hyderabad (Telangana) [India], July 20 (ANI): Hyderabad-based Bharat Biotech on Wednesday announced that the administration of the third dose of its COVID-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses against both
Hyderabad (Telangana) [India], July 15 (ANI): Amid the ongoing 75 days COVID-19 booster dose drive, Urban Primary Health Centre's Medical in-charge of Gaganmahal, Hyderabad, Dr Raja Lakshmi said that the centres are having sufficient amount of stock of both Covishield and Covaxin.
New Delhi [India], July 11 (ANI): The National Technical Advisory Group on Immunisation (NTAGI's) Covid working group is expected to conduct a meeting soon to discuss India's first mRNA vaccine against COVID and Biological E's Corbevax Booster dose for Covishield and Covaxin beneficiaries
Thimpu [Bhutan], July 10 (ANI): In order to curb the spread of COVID-19, the United States delivered 33,600 doses of the Pfizer pediatric COVID-19 vaccine to Bhutan, in partnership with COVAX and the Bhutan Foundation, an official statement said on Sunday.